DONGSHAN ZHANG,HONGJUN ZHANG,JOS CALS,KENNETH JAY BARR,MARIO VAN DER STELT,RICHARD THOMAS BERESIS,RITA CORTE REAL GONÇALVES AZEVEDO,WILLEM FREDERIK JOHAN KARSTENS,XIAOBANG DUAN
申请号:
BR112013020352
公开号:
BR112013020352A2
申请日:
2012.02.10
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to compounds according to general Formula I or a pharmaceutically acceptable salt thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.